Automated And Closed Cell Therapy Processing Systems Market Is Projected To Reach USD 2.94 Billion By 2028

Comments · 246 Views

The global automated and closed cell therapy processing systems market size was valued at USD 615.0 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 21.7% from 2021 to 2028.

Automated And Closed Cell Therapy Processing Systems Industry Overview

The global automated and closed cell therapy processing systems market size was valued at USD 615.0 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 21.7% from 2021 to 2028. 

The growing popularity of regenerative medicines  cell therapies coupled with a range of benefits offered by automation technologies for the development of these therapies is expected to propel the market growth. In addition, the growing integration of software technologies and advanced therapy development processes is also projected to boost the market. Furthermore, rising investments by bio manufacturers for the development of cellular therapy products through rounds of series funding are anticipated to offer lucrative opportunities to or the market.

Gather more insights about the market drivers, restrains and growth of the Global Automated And Closed Cell Therapy Processing Systems Market

In recent years, there has been massive growth in clinical trials associated with advanced therapies. This growth has led to an increase in demand for advanced and automated technologies to achieve high throughput and yield. This can be attributed to the fact that automated and closed systems offer better cell handling capabilities and reduce the possibility of errors during bioprocessing. 

The availability of a range of systems to offer both automated integrated workflow solutions and partial automation is expected to spur the adoption rate in the space. Furthermore, the system also enables continuous monitoring of controlled therapy processing, which is being conducted for the development of new therapeutic platforms. In addition, integrated intelligent algorithms facilitate high precision. Market players are actively engaged in the development of infrastructure to leverage the production of automated systems.

For instance, in June 2021, the collaboration of Lonza and Cell Point announced its plan to utilize the Cocoon platform for the development of T-cell-based therapies. The project is being conducted to provide a proof of concept for Point-of-Care (POC) production to optimize the supply chain operations. Also, as automated systems can enhance analytical testing and facilitate quality control, the systems are expected to witness substantial acceptance during the forecast period.

Browse through Grand View Research's Biotechnology Industry Research Reports

  • Cell Reprogramming Market: The global cell reprogramming market size was valued at USD 311.66 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2022 to 2030.
  • Cell Culture Market: The global cell culture market size was valued at USD 21.05 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 11.9% from 2022 to 2030.

Automated And Closed Cell Therapy Processing Systems Market Segmentation 

Grand View Research has segmented the global automated and closed cell therapy processing systems market on the basis of workflow, type, scale, and region:

Automated Closed Cell Therapy Processing Systems Workflow Outlook (Revenue, USD Million, 2017 - 2028)

  • Separation
  • Expansion
  • Apheresis
  • Fill-Finish
  • Cryopreservation
  • Others

Automated Closed Cell Therapy Processing Systems Type Outlook (Revenue, USD Million, 2017 - 2028)

  • Stem Cell Therapy
  • Non-stem Cell Therapy

Automated Closed Cell Therapy Processing Systems Scale Outlook (Revenue, USD Million, 2017 - 2028)

  • Pre-commercial/RD Scale
  • Commercial Scale

Automated Closed Cell Therapy Processing Systems Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East Africa 

Market Share Insights

  • February 2021: Cytiva and Brooks Life sciences agreed to extend the capabilities of the automated cold chain. The companies are working together to enhance the cryogenic cold chain capabilities of Cytiva’s automated cold chain system.
  • January 2021: Fresenius Kabiformed a joint venture with Bio-Techne to launch ScaleReady, to develop a scalable and versatile therapy manufacturing platform. 

Key Companies profiled:

Some of the prominent players in the global automated and closed cell therapy processing systems market include:

  • MiltenyiBiotec
  • Lonza
  • Fresenius Kabi
  • Cytiva (Danaher Corp.)
  • BioSpherix, Ltd.
  • Terumo Corporation
  • Sartorius AG
  • ThermoGenesis Holdings, Inc.
  • Cellares Inc.
  • Thermo Fisher Scientific, Inc. 

Order a free sample PDF of the Automated And Closed Cell Therapy Processing Systems Market Intelligence Study, published by Grand View Research. 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments